278 related articles for article (PubMed ID: 24735448)
1. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
[TBL] [Abstract][Full Text] [Related]
2. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
[TBL] [Abstract][Full Text] [Related]
4. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
5. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
[TBL] [Abstract][Full Text] [Related]
6. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
8. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.
Yuan A; Wu J; Song C; Tang X; Qiao Q; Zhao L; Gong G; Hu Y
J Pharm Sci; 2013 May; 102(5):1626-35. PubMed ID: 23423631
[TBL] [Abstract][Full Text] [Related]
9. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
12. A pH/enzyme-responsive tumor-specific delivery system for doxorubicin.
Dong L; Xia S; Wu K; Huang Z; Chen H; Chen J; Zhang J
Biomaterials; 2010 Aug; 31(24):6309-16. PubMed ID: 20472287
[TBL] [Abstract][Full Text] [Related]
13. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
14. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
[TBL] [Abstract][Full Text] [Related]
15. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
16. PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery.
Zhang W; Sun J; Liu Y; Tao M; Ai X; Su X; Cai C; Tang Y; Feng Z; Yan X; Chen G; He Z
Mol Pharm; 2014 Oct; 11(10):3279-90. PubMed ID: 24754897
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
19. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y
Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
